These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
303 related articles for article (PubMed ID: 34919258)
1. Possible mechanistic insights into iron homeostasis role of the action of 4-aminoquinolines (chloroquine/hydroxychloroquine) on COVID-19 (SARS-CoV-2) infection. Batiha GE; Shaheen HM; Al-Kuraishy HM; Teibo JO; Akinfe OA; Al-Garbee AI; Teibo TKA; Kabrah SM Eur Rev Med Pharmacol Sci; 2021 Dec; 25(23):7565-7584. PubMed ID: 34919258 [TBL] [Abstract][Full Text] [Related]
2. The possible mechanisms of action of 4-aminoquinolines (chloroquine/hydroxychloroquine) against Sars-Cov-2 infection (COVID-19): A role for iron homeostasis? Quiros Roldan E; Biasiotto G; Magro P; Zanella I Pharmacol Res; 2020 Aug; 158():104904. PubMed ID: 32430286 [TBL] [Abstract][Full Text] [Related]
3. Repurposing of well-known medications as antivirals: hydroxychloroquine and chloroquine - from HIV-1 infection to COVID-19. Naghipour S; Ghodousi M; Rahsepar S; Elyasi S Expert Rev Anti Infect Ther; 2020 Nov; 18(11):1119-1133. PubMed ID: 32631083 [TBL] [Abstract][Full Text] [Related]
4. Advances in the use of chloroquine and hydroxychloroquine for the treatment of COVID-19. Sun J; Chen Y; Fan X; Wang X; Han Q; Liu Z Postgrad Med; 2020 Sep; 132(7):604-613. PubMed ID: 32496926 [TBL] [Abstract][Full Text] [Related]
5. A review on possible modes of action of chloroquine/hydroxychloroquine: repurposing against SAR-CoV-2 (COVID-19) pandemic. Tripathy S; Dassarma B; Roy S; Chabalala H; Matsabisa MG Int J Antimicrob Agents; 2020 Aug; 56(2):106028. PubMed ID: 32450198 [TBL] [Abstract][Full Text] [Related]
6. COVID-19 Pandemic - A Narrative Review of the Potential Roles of Chloroquine and Hydroxychloroquine. de Barros CM; Almeida CAF; Pereira B; Costa KCM; Pinheiro FA; Maia LDB; Trindade CM; Garcia RCT; Torres LH; Diwan S; Boralli VB Pain Physician; 2020 Aug; 23(4S):S351-S366. PubMed ID: 32942793 [TBL] [Abstract][Full Text] [Related]
7. Clinical evidence for repurposing chloroquine and hydroxychloroquine as antiviral agents: a systematic review. Rodrigo C; Fernando SD; Rajapakse S Clin Microbiol Infect; 2020 Aug; 26(8):979-987. PubMed ID: 32470568 [TBL] [Abstract][Full Text] [Related]
8. Chloroquine and hydroxychloroquine in the treatment of COVID-19: the never-ending story. Gasmi A; Peana M; Noor S; Lysiuk R; Menzel A; Gasmi Benahmed A; Bjørklund G Appl Microbiol Biotechnol; 2021 Feb; 105(4):1333-1343. PubMed ID: 33515285 [TBL] [Abstract][Full Text] [Related]
9. Facts and Myths: Efficacies of Repurposing Chloroquine and Hydroxychloroquine for the Treatment of COVID-19. Al-Bari AA Curr Drug Targets; 2020; 21(16):1703-1721. PubMed ID: 32552642 [TBL] [Abstract][Full Text] [Related]
10. What makes (hydroxy)chloroquine ineffective against COVID-19: insights from cell biology. Altulea D; Maassen S; Baranov MV; van den Bogaart G J Mol Cell Biol; 2021 Jul; 13(3):175-184. PubMed ID: 33693723 [TBL] [Abstract][Full Text] [Related]
11. Chloroquine and hydroxychloroquine in the treatment of malaria and repurposing in treating COVID-19. Lei ZN; Wu ZX; Dong S; Yang DH; Zhang L; Ke Z; Zou C; Chen ZS Pharmacol Ther; 2020 Dec; 216():107672. PubMed ID: 32910933 [TBL] [Abstract][Full Text] [Related]
12. A systematic review of the prophylactic role of chloroquine and hydroxychloroquine in coronavirus disease-19 (COVID-19). Shah S; Das S; Jain A; Misra DP; Negi VS Int J Rheum Dis; 2020 May; 23(5):613-619. PubMed ID: 32281213 [TBL] [Abstract][Full Text] [Related]
13. Chloroquine and Hydroxychloroquine in COVID-19: Practice Implications for Healthcare Professionals. Mallhi TH; Ahmad A; Butt MH; Misbah S; Khan YH; Alotaibi NH J Coll Physicians Surg Pak; 2020 Oct; 30(10):124-128. PubMed ID: 33115586 [TBL] [Abstract][Full Text] [Related]
14. In silico study of azithromycin, chloroquine and hydroxychloroquine and their potential mechanisms of action against SARS-CoV-2 infection. Braz HLB; Silveira JAM; Marinho AD; de Moraes MEA; Moraes Filho MO; Monteiro HSA; Jorge RJB Int J Antimicrob Agents; 2020 Sep; 56(3):106119. PubMed ID: 32738306 [TBL] [Abstract][Full Text] [Related]
15. Hydroxychloroquine and chloroquine retinal safety concerns during COVID-19 outbreak. Nicolò M; Ferro Desideri L; Bassetti M; Traverso CE Int Ophthalmol; 2021 Feb; 41(2):719-725. PubMed ID: 32946004 [TBL] [Abstract][Full Text] [Related]
16. Autophagy as an emerging target for COVID-19: lessons from an old friend, chloroquine. Bonam SR; Muller S; Bayry J; Klionsky DJ Autophagy; 2020 Dec; 16(12):2260-2266. PubMed ID: 32522067 [TBL] [Abstract][Full Text] [Related]
17. Effects of chloroquine or hydroxychloroquine treatment on non-SARS-CoV2 viral infections: A systematic review of clinical studies. Cui X; Sun J; Minkove SJ; Li Y; Cooper D; Couse Z; Eichacker PQ; Torabi-Parizi P Rev Med Virol; 2021 Nov; 31(6):e2228. PubMed ID: 33694220 [TBL] [Abstract][Full Text] [Related]
18. Janus sword actions of chloroquine and hydroxychloroquine against COVID-19. Chen X; Geiger JD Cell Signal; 2020 Sep; 73():109706. PubMed ID: 32629149 [TBL] [Abstract][Full Text] [Related]
19. Chloroquine and hydroxychloroquine as ACE2 blockers to inhibit viropexis of 2019-nCoV Spike pseudotyped virus. Wang N; Han S; Liu R; Meng L; He H; Zhang Y; Wang C; Lv Y; Wang J; Li X; Ding Y; Fu J; Hou Y; Lu W; Ma W; Zhan Y; Dai B; Zhang J; Pan X; Hu S; Gao J; Jia Q; Zhang L; Ge S; Wang S; Liang P; Hu T; Lu J; Wang X; Zhou H; Ta W; Wang Y; Lu S; He L Phytomedicine; 2020 Dec; 79():153333. PubMed ID: 32920291 [TBL] [Abstract][Full Text] [Related]
20. New Anti SARS-Cov-2 Targets for Quinoline Derivatives Chloroquine and Hydroxychloroquine. Gentile D; Fuochi V; Rescifina A; Furneri PM Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32824072 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]